These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22110695)

  • 1. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe.
    Kissling E; Valenciano M; Cohen JM; Oroszi B; Barret AS; Rizzo C; Stefanoff P; Nunes B; Pitigoi D; Larrauri A; Daviaud I; Horvath JK; O'Donnell J; Seyler T; Paradowska-Stankiewicz IA; Pechirra P; Ivanciuc AE; Jiménez-Jorge S; Savulescu C; Ciancio BC; Moren A
    PLoS One; 2011; 6(11):e27622. PubMed ID: 22110695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.
    Valenciano M; Kissling E; Cohen JM; Oroszi B; Barret AS; Rizzo C; Nunes B; Pitigoi D; Larrauri Cámara A; Mosnier A; Horvath JK; O'Donnell J; Bella A; Guiomar R; Lupulescu E; Savulescu C; Ciancio BC; Kramarz P; Moren A
    PLoS Med; 2011 Jan; 8(1):e1000388. PubMed ID: 21379316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
    Kissling E; Valenciano M; Pozo F; Vilcu AM; Reuss A; Rizzo C; Larrauri A; Horváth JK; Brytting M; Domegan L; Korczyńska M; Meijer A; Machado A; Ivanciuc A; Višekruna Vučina V; van der Werf S; Schweiger B; Bella A; Gherasim A; Ferenczi A; Zakikhany K; O Donnell J; Paradowska-Stankiewicz I; Dijkstra F; Guiomar R; Lazar M; Kurečić Filipović S; Johansen K; Moren A;
    Influenza Other Respir Viruses; 2018 Jul; 12(4):423-437. PubMed ID: 29125681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
    Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
    Maurel M; Mazagatos C; Goerlitz L; Oroszi B; Hooiveld M; Machado A; Domegan L; Ilić M; Popescu R; Sève N; Martínez-Baz I; Larrauri A; Buda S; Túri G; Meijer A; Gomez V; O'Donnell J; Mlinarić I; Timnea O; Diez AO; Dürrwald R; Horváth JK; Dijkstra F; Rodrigues AP; McKenna A; Filipović SK; Lazar M; Kaczmarek M; Bacci S; Kissling E;
    Vaccine; 2024 Jun; 42(16):3547-3554. PubMed ID: 38704257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study.
    Kissling E; Valenciano M;
    Euro Surveill; 2011 Mar; 16(11):. PubMed ID: 21435329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.
    Savulescu C; Jiménez-Jorge S; Delgado-Sanz C; de Mateo S; Pozo F; Casas I; Larrauri A;
    Vaccine; 2014 Jul; 32(35):4404-4411. PubMed ID: 24968153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.
    Jiménez-Jorge S; de Mateo S; Delgado-Sanz C; Pozo F; Casas I; Garcia-Cenoz M; Castilla J; Pérez E; Gallardo V; Rodriguez C; Vega T; Quiñones C; Martínez E; Vanrell JM; Giménez J; Castrillejo D; Serrano Mdel C; Ramos JM; Larrauri A;
    BMC Infect Dis; 2013 Sep; 13():441. PubMed ID: 24053661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12.
    Kissling E; Valenciano M;
    Euro Surveill; 2012 Apr; 17(15):. PubMed ID: 22516046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
    Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A
    Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
    Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China.
    Wang Y; Zhang T; Chen L; Greene C; Ding Y; Cheng Y; Yang C; Zeng S; Hua J; Zhou S; Song Y; Luan L; Zhang J; Zhao G
    Vaccine; 2016 May; 34(21):2460-2465. PubMed ID: 27016650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
    Kissling E; Pozo F; Martínez-Baz I; Buda S; Vilcu AM; Domegan L; Mazagatos C; Dijkstra F; Latorre-Margalef N; Kurečić Filipović S; Machado A; Lazar M; Casado I; Dürrwald R; van der Werf S; O'Donnell J; Linares Dopido JA; Meijer A; Riess M; Višekruna Vučina V; Rodrigues AP; Mihai ME; Castilla J; Goerlitz L; Falchi A; Connell J; Castrillejo D; Hooiveld M; Carnahan A; Ilić M; Guiomar R; Ivanciuc A; Maurel M; Omokanye A; Valenciano M;
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13069. PubMed ID: 36702797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.
    Sullivan SG; Carville KS; Chilver M; Fielding JE; Grant KA; Kelly H; Levy A; Stocks NP; Tempone SS; Regan AK
    Epidemiol Infect; 2016 Aug; 144(11):2317-28. PubMed ID: 27125368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
    Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.